Humana (HUM) Stock Price & Analysis

HUM$385.70-57.63 -13.00%
Medical - Healthcare PlansLarge Cap
Compare
Market cap$46.32BEnterprise value$59.62BRevenue (TTM)$154.19BMarket positionTop 25%

Score

35
Bearish
Value
39
Quality
37
Growth
28

AI Analysis

Snapshot

Humana doesn’t screen as a clean setup today — Stocklytics 35/100 leaves more to prove. Under the hood: P/E 43.4, rich vs its own history, plus revenue compounding ~12% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

39
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

28
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

37
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Humana Inc. (HUM) last printed $385.70. Equity value is $46.32B. Trailing earnings multiple 42.47. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$54.41B$53.8B$56.94B$64.93B$77.19B$83.65B$92.92B$106.44B$117.81B$129.66B

About

Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.

Humana (HUM) Stock Price & Analysis

HUM price $385.70 -57.63 -13.00%

Ticker
HUM
Price
$385.70
Change
-57.63 -13.00%
Market cap
$46.32B
P/E
42.47
Forward P/E
9.99
Dividend yield
0.79%
Beta
0.74
Sector
Healthcare
Industry
Medical - Healthcare Plans
Stocklytics score
35
Value
39
Quality
37
Growth
28

Stocklytics score rationale: value 39, quality 37, growth 28.

AI Score 65. Humana Inc. has a market cap of $49.77 billion and a price of $414.5, but its high price-to-earnings ratio of approximately 39 indicates potential overvaluation

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener